Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 25.98
-0.49 (-1.85%)
At close: Sep 2, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.34 billion as of September 1, 2026. Its market cap has decreased by -27.53% in one year.
Market Cap
2.34B
Enterprise Value
1.20B
Revenue
394.29M
Ranking
n/a
PE Ratio
355.26
Stock Price
25.98
ChartMarket Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.34B, a decrease of -61.54%. That is a compound annual growth rate of -19.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 2.34B | -19.54% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 2.77B |
| Shenzhen Bioeasy Biotechnology | 2.69B |
| Yantai Zhenghai Biotechnology | 2.68B |
| Shanghai Universal Biotech | 2.52B |
| Shandong Sito Bio-technology | 2.46B |
| Zhejiang East Asia Pharmaceutical | 2.41B |
| Jilin Jian Yisheng Pharmaceutical | 2.36B |
| Jiangsu CoWin Biotech | 2.28B |